title: The efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism.
authors.forename: M-C
authors.initials: MC
authors.lastname: Chen
authors.forename: C-T
authors.initials: CT
authors.lastname: Hu
authors.forename: L-Y
authors.initials: LY
authors.lastname: Wang
authors.forename: H H
authors.initials: HH
authors.lastname: Lin
mesh_terms: D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D065731:Cytochrome P-450 CYP2C19; D005838:Genotype; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D006899:Mixed Function Oxygenases / Q000235:genetics*; D054328:Proton Pump Inhibitors
chemical_list: D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors; D006899:Mixed Function Oxygenases; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19